Skip to main content
. 2021 Oct 15;12:759249. doi: 10.3389/fphar.2021.759249

FIGURE 3.

FIGURE 3

Forest plots of H. pylori cure rates of LPZ-amoxicillin-clarithromycin regimen among different CYP2C19 genotypes in the fixed-effects model. (A) CYP2C19 EMs vs IMs, (B) EMs vs PMs and (C) IMs and PMs.; Abbreviations: CI, confidence interval; EM, extensive metabolizer of CYP2C19; IM, intermediate metabolizer of CYP2C19; LPZ, lansoprazole; PPI, proton pump inhibitor; PM, poor metabolizer of CYP2C19; PPI, proton pump inhibitor.